UNSPSC 85516056: Supplement left femoral artery with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left femoral artery with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04UL4JZ

UNSPSC 85516056 Supplement left femoral artery with synthetic substitute, percutaneous endoscopic approach is a Commodity code that does not align with the recent state and local procurement activity posted under it. The code nominally describes a specific surgical procedure — endovascular repair of a femoral artery — but the recent opportunities tagged to this code are actually for occupational and disability medical surveillance, pharmacy benefit management, emergency and specialty medical services for youth in custody, temporary health professional staffing, and surgical benefit carve-out programs for municipal employee health plans. None of these solicitations involve the procedure the code purports to describe. The mismatch suggests either a systematic tagging error in the source data or that the code is being misapplied to health service procurement more broadly.

The issuing bodies include a state transportation department (Washington), county health systems and boards (Collier County, Santa Clara County, Harris County), and municipal retirement and benefits offices (City of Phoenix, City of Long Beach), spanning Arizona, California, Florida, and Washington. Without recent opportunities that actually match the code's nominal scope, there is no meaningful activity to characterize under this code at present. State and local governments do not appear to be actively procuring the specific surgical procedure the code names; instead, they are procuring the administrative and staffing infrastructure around health service delivery. A business development firm evaluating pursuit under this code should treat it as inactive for direct product or service delivery and investigate whether the actual work aligns with health services administration or temporary staffing categories instead.